Sarepta Therapeutics Inc (SRPT):企業の財務・戦略的SWOT分析

◆英語タイトル:Sarepta Therapeutics Inc (SRPT) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH38603FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:59
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Sarepta Therapeutics Inc (SRPT) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sarepta Therapeutics Inc (Sarepta) discovers and develops unique RNA-targeted therapeutics to treat rare neuromuscular diseases. The company develops drugs based on its proprietary platform technology, phosphorodiamidate morpholino oligomer (PMO) chemistries. Its commercial products include, Exondys 51, indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene. Its other commercial product, Vyondys 53 injection is indicated for the treatment of DMD in patients who have a confirmed mutation of the DMD gene that is responsive to exon 53 skipping. Sarepta is headquartered in Cambridge, Massachusetts, the US.

Sarepta Therapeutics Inc Key Recent Developments

Dec 14,2020: Sarepta Therapeutics announces executive management changes
Nov 05,2020: Sarepta Therapeutics announces third quarter 2020 financial results and recent corporate developments
Sep 14,2020: Long-term functional data from Sarepta Therapeutics most advanced gene therapy programs to be presented at Upcoming Annual Congress of the World Muscle Society
Sep 03,2020: JM to manufacture regulatory starting materials for Sarepta Therapeutics
Aug 11,2020: Sarepta Therapeutics and University of Florida announce collaboration to accelerate the discovery and development of therapies for rare genetic diseases

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Sarepta Therapeutics Inc – Key Facts
Sarepta Therapeutics Inc – Key Employees
Sarepta Therapeutics Inc – Key Employee Biographies
Sarepta Therapeutics Inc – Major Products and Services
Sarepta Therapeutics Inc – History
Sarepta Therapeutics Inc – Company Statement
Sarepta Therapeutics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Sarepta Therapeutics Inc – Business Description
Sarepta Therapeutics Inc – Corporate Strategy
Sarepta Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Sarepta Therapeutics Inc – Strengths
Sarepta Therapeutics Inc – Weaknesses
Sarepta Therapeutics Inc – Opportunities
Sarepta Therapeutics Inc – Threats
Sarepta Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Sarepta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sarepta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Sarepta Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Dec 14, 2020: Sarepta Therapeutics announces executive management changes
Nov 05, 2020: Sarepta Therapeutics announces third quarter 2020 financial results and recent corporate developments
Sep 14, 2020: Long-term functional data from Sarepta Therapeutics most advanced gene therapy programs to be presented at Upcoming Annual Congress of the World Muscle Society
Sep 03, 2020: JM to manufacture regulatory starting materials for Sarepta Therapeutics
Aug 11, 2020: Sarepta Therapeutics and University of Florida announce collaboration to accelerate the discovery and development of therapies for rare genetic diseases
Aug 05, 2020: Sarepta Therapeutics announces second quarter 2020 financial results and recent corporate developments
Aug 03, 2020: Sarepta Therapeutics : Appointment of certain officers
Jun 30, 2020: Sarepta Therapeutics announces retirement of Sandy Mahatme, Chief Financial Officer and Chief Business Officer
Jun 30, 2020: Sarepta Therapeutics announces the inducement grants under Nasdaq listing rule 5635(c)(4)
Jun 30, 2020: Sarepta Therapeutics: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Sarepta Therapeutics Inc, Key Facts
Sarepta Therapeutics Inc, Key Employees
Sarepta Therapeutics Inc, Key Employee Biographies
Sarepta Therapeutics Inc, Major Products and Services
Sarepta Therapeutics Inc, History
Sarepta Therapeutics Inc, Other Locations
Sarepta Therapeutics Inc, Subsidiaries
Sarepta Therapeutics Inc, Key Competitors
Sarepta Therapeutics Inc, Ratios based on current share price
Sarepta Therapeutics Inc, Annual Ratios
Sarepta Therapeutics Inc, Annual Ratios (Cont...1)
Sarepta Therapeutics Inc, Interim Ratios
Sarepta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sarepta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Sarepta Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Sarepta Therapeutics Inc (SRPT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Severn Trent Plc:企業の戦略・SWOT・財務情報
    Severn Trent Plc - Strategy, SWOT and Corporate Finance Report Summary Severn Trent Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Nanoco Group Plc (NANO):企業の財務・戦略的SWOT分析
    Nanoco Group Plc (NANO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Duke Energy Indiana, LLC:発電所・企業SWOT分析
    Duke Energy Indiana, LLC - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Gem Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Gem Pharmaceuticals LLC (Gem Pharmaceuticals) is a clinical-stage biopharmaceutical company that develops proprietary anthracycline derivatives. The company’s pipeline products include GPX-150 for oncology, topical GPX-150 for inflammation, GPX 150 oral formulations and potency analogues pro …
  • Ingersoll-Rand plc:企業の戦略・SWOT・財務情報
    Ingersoll-Rand plc - Strategy, SWOT and Corporate Finance Report Summary Ingersoll-Rand plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Cadogan Petroleum Plc (CAD):石油・ガス:M&Aディール及び事業提携情報
    Summary Cadogan Petroleum Plc (Cadogan) is an independent upstream energy company that carries out exploration, development and production of oil and gas. It also conducts gas trading operations, which include the import of gas from European countries, and purchase and sale in the domestic market. T …
  • Clark Public Utilities:企業の戦略的SWOT分析
    Clark Public Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Naked Wines plc (WINE):企業の財務・戦略的SWOT分析
    Naked Wines plc (WINE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Hindustan Unilever Ltd (HINDUNILVR):企業の財務・戦略的SWOT分析
    Hindustan Unilever Ltd (HINDUNILVR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • FHI 360:企業の戦略的SWOT分析
    FHI 360 - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Aethlon Medical Inc (AEMD):医療機器:M&Aディール及び事業提携情報
    Summary Aethlon Medical Inc (Aethlon Medical) is a developer of therapeutic technologies that address unmet needs in biodefense and global health. It develops immunotherapeutic technologies for the treatment of cancer and infectious diseases. The company’s lead product, Hemopurifier, strengthens nat …
  • The Toro Company:戦略・SWOT・企業財務分析
    The Toro Company - Strategy, SWOT and Corporate Finance Report Summary The Toro Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • United Food Holdings Limited:戦略・SWOT・企業財務分析
    United Food Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary United Food Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Lepu Medical Technology (Beijing) Co Ltd (300003)-医療機器分野:企業M&A・提携分析
    Summary Lepu Medical Technology (Beijing) Co Ltd (Lepu Medical) is a medical device company that designs, develops, and distributes medical equipments. The company’s products include interventional cardiology products, cardiac in vitro diagnosis products, occlusion devices, pacemaker, angiographic e …
  • Sumitomo Dainippon Pharma Co., Ltd.:企業の戦略・SWOT・財務分析
    Sumitomo Dainippon Pharma Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Dainippon Pharma Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Maple Leaf Foods Inc (MFI):企業の財務・戦略的SWOT分析
    Maple Leaf Foods Inc (MFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • RUAG Holding AG:企業の戦略・SWOT・財務情報
    RUAG Holding AG - Strategy, SWOT and Corporate Finance Report Summary RUAG Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Verizon Communications Inc (VZ):企業の財務・戦略的SWOT分析
    Verizon Communications Inc (VZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Wellington Pub Company PLC:企業の戦略・SWOT・財務情報
    Wellington Pub Company PLC - Strategy, SWOT and Corporate Finance Report Summary Wellington Pub Company PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Daito Trust Construction Co., Ltd.:企業の戦略・SWOT・財務情報
    Daito Trust Construction Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daito Trust Construction Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆